Further, knockdown of Rb in a cancer cell line inhibited SAHF formation in response to doxorubicin, suggesting Rb may play a role in tumor cell SAHF formation after treatment with DNA-damaging agents [88]. The gene discussed is RB1; the disease is cancer.